The Board of Directors of UCrest Berhad announced that the Company had on 14 August 2023 entered into a Collaborative Agreement ("CA") with Hangsukeji to jointly develop the Artificial Intelligence (AI) 3D printing business for the healthcare market in addition to the manufacturing industry. In accordance with the CA, the AI 3D printing products will carry the UCrest brand, Hangsukeji will be marketing the products, materials, and services in China while UCrest will be developing the market outside China. RATIONALE, BENEFIT and PROSPECT.

Expanding the 3D printing into healthcare product with AI technology, with the aim to continue to build the ecosystem of digital health.